John Houston: Thanks for the great write up on the exciting events happening at Arvinas!

John Houston, Chairperson, CEO and President at Arvinas (NASDAQ ARVN), shared the following post by Hartford Business Journal on LinkedIn, adding the following:

“Thanks for the great write up on the exciting events happening at Arvinas!”

Quoting Hartford Business Journal:

“With a recent $350 million fundraise, New Haven biotech Arvinas says it’s financed through at least 2027 to pursue bringing its cancer-fighting drugs to market.”

Read further.
Source: John Houston/LinkedIn and Hartford Business Journal/LinkedIn